Fasenra Approved in US For Treating GPA Wegner’s Disease in Adults
AstraZeneca’s Fasenra approved in the US for treating eosinophilic granulomatosis with polyangiitis.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
